A Prescription Drug User Fee Act target date of December 27, 2024 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application ...
REDWOOD CITY, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, ...
One review by researchers at University of North Carolina found that non-alcoholic fatty liver disease can lead to liver injury and hepatocarcinoma (the most common type of primary liver cancer). This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback